Comparative activities of the S-enantiomer and racemic forms of equol on bone fragility in ovariectomized mice

Bioscience, Biotechnology and Biochemistry

Volumn 76, Issue 5, 2012, Pages 1018-1021

  Kimira, Yoshifumi ^a   Katsumata, Shin Ichi ^a   Suzuki, Kazuharu ^a   Ishimi, Yoshiko ^b   Ueno, Tomomi ^c   Uchiyama, Shigeto ^c   Adlercreutz, Herman ^d   Uehara, Mariko ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Osteoporosis; Ovariectomized mice; Racemic( ) equol; S( ) equol; Soy isoflavones

Indexed keywords

BONE FRAGILITY; BONE MINERAL DENSITY; BONE STRENGTH; INHIBITORY EFFECT; OSTEOPOROSIS; OVARIECTOMIZED MICE; S(-)-EQUOL; SOY ISOFLAVONES;

BODY FLUIDS; BONE; CHIRALITY; ENANTIOMERS;

MAMMALS;

EQUOL; PHYTOESTROGEN;

ANIMAL; ARTICLE; BLOOD; BONE DENSITY; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; FEMALE; FEMUR; FRAGILITY FRACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; MOUSE; OSTEOPOROSIS; OVARIECTOMY; STEREOISOMERISM; URINE;

ANIMALS; BONE DENSITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; EQUOL; FEMALE; FEMUR; HUMANS; MICE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; OVARIECTOMY; PHYTOESTROGENS; STEREOISOMERISM;

MUS;

EID: 84861446985     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.110973     Document Type: Article

References (18)

1. Beral V, Bull D, and Reeves G, Lancet, 365, 1543-1551 (2005).
2. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, and Masamune Y, Biol. Pharm. Bull., 24, 351-356 (2001).
3. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, and Ikegami S, Endocrinology, 140, 1893-1900 (1999).
4. Setchell KDR, Brown NM, and Lydeking-Olsen E, J. Nutr., 132, 3577-3584 (2002).
5. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K, and Ishimi Y, J. Nutr., 134, 2623-2627 (2004).
6. Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, and Heubi JE, Am. J. Clin. Nutr., 81, 1072-1079 (2005).
7. Tousen Y, Ezaki J, Fujii Y, Ueno T, Nishimuta M, and Ishimi Y, Menopause, 18, 563-574 (2011).
8. Aso T, Uchiyama S, Matsumura Y, Taguchi M, Nozaki M, Takamatsu K, Ishizuka B, Kubota T, Mizunuma H, and Ohta H, J. Women's Health, 21, 92-100 (2012).
9. Onoda A, Ueno T, Uchiyama S, Hayashi S, Kato K, and Wake N, Food Chem. Toxicol., 49, 2279-2284 (2011).
10. Yoneda T, Ueno T, and Uchiyama S, Menopause, 18, 814-820 (2011).
11. Reeves PG, Nielsen FH, and Fahey GC Jr, J. Nutr., 123, 1939-1951 (1993).
12. Yee S, Burdock GA, Kurata Y, Enomoto Y, Narumi K, Hamada S, Itoh T, Shimomura Y, and Ueno T, Food Chem. Toxicol., 46, 2713-2720 (2008).
13. Peñalvo JL and Nurmi T, J. Pharm. Biomed. Anal., 41, 1497-1567 (2006).
14. Katsumata SI, Uehara M, Ishimi Y, Adlercreutz H, and Suzuki K, J. Clin. Biochem. Nutr., 43 S, 136-140 (2008).
15. Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uehara M, and Ishimi Y, Menopause, 14, 866-874 (2007).
16. Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, Kim MO, and Setchell KD, Carcinogenesis, 31, 886-893 (2010).
17. Setchell KD, Zhao X, Jha P, Heubi JE, and Brown NM, Am. J. Clin. Nutr., 90, 1029-1037 (2009).
18. Wen Z, Tallman MN, Ali SY, and Smith PC, Drug Metab. Dispos., 35, 371-380 (2007).